Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoclonal Antibody Therapy in Alzheimer’s Disease
Monica Neațu, Anca Covaliu, Iulia Ioniță, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 60-60
Open Access | Times Cited: 14

Showing 14 citing articles:

Unraveling Alzheimer’s: the promise of aducanumab, lecanemab, and donanemab
Taha Basit Ameen, Syeda Naveera Kashif, Syed Muhammad Iraj Abbas, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 9
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 7
Osteoporosis and Alzheimer´s disease (or Alzheimer´s disease and Osteoporosis)
Nahuel Ezequiel Wanionok, Gustavo R Morel, Juan Manuel Fernández
Ageing Research Reviews (2024) Vol. 99, pp. 102408-102408
Closed Access | Times Cited: 5
Alzheimer’s Disease: Recent Developments in Pathogenesis, Diagnosis, and Therapy
Ivana Shawkatová, Juraj Javor
Life (2025) Vol. 15, Iss. 4, pp. 549-549
Open Access
In Vivo Analysis Techniques for Antibody Drug: Recent Advances and Methodological Insights
Xiaodan Miao, Beilei Sun, Jian Zhang, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101314-101314
Open Access
The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer’s, and Parkinson’s disease’
Yahveth Cantero‐Fortiz, Merçé Boada
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
Thomas Gabriel Schreiner, Cristina Croitoru, Diana Nicoleta Hodorog, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 2
Modulating tumor-associated macrophage polarization by anti-maRCO mAb exerts anti-osteosarcoma effects through regulating osteosarcoma cell proliferation, migration and apoptosis
Lei Ding, Ling Wu, Yuting Cao, et al.
Journal of Orthopaedic Surgery and Research (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Neuroprotective Effects of Phenolic Constituents from Drynariae Rhizoma
Jin Ahn, Chung Hyeon Lee, Xiang‐Qian Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 2
Exploring the effectiveness and safety profile of TAU protein antibodies as potential therapies for alzheimer's disease: a comprehensive review
Muhammad Essa, N. Zaheer Ahmed, Amanullah Kakar, et al.
(2024)
Open Access | Times Cited: 1
Single MAPT knock-in mouse models of frontotemporal dementia for sharing with the neurodegenerative research community
T Morito, Meng Qi, Naoko Kamano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Nanotechnological advancement for the treatment of neurodegenerative disorders
Garima Rai, Surbhi Sharma, Aditi Singh, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-19
Closed Access | Times Cited: 1
Potentiality of Marine Microbial Metabolites in the Remedy of Alzheimer’s Disease: A Comprehensive Review
Srijita Paul, Mouli Dey, Bishnupriya Roy, et al.
Proceedings of the Zoological Society (2024) Vol. 77, Iss. 3, pp. 293-303
Closed Access
Prodrugs for neurodegenerative diseases
Paolo Guglielmi, Arianna Granese, Daniela Secci, et al.
Elsevier eBooks (2024), pp. 265-284
Closed Access
Page 1

Scroll to top